中文
|
English
Home
|
Help
|
Contact
Return
Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
10.3350/cmh.2020.0099
Author:
Byoung Kuk JANG
1
Author Information
1. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
Publication Type:
Editorial
From:
Clinical and Molecular Hepatology 2020;26(3):312-314
Country
Republic of Korea
Language:
0